“Novel Sustained-Release Nateglinide Microspheres: In Vitro Evaluation for Improved Antidiabetic Therapy” (2025) Journal of Carcinogenesis, 24(6s), pp. 232–242. doi:10.64149/J.Carcinog.24.6s.232-242.